Diana was diagnosed in 2015 with ovarian cancer, and since then has been an advocate for clinical trials.
Clark Center for Radiation Oncology
Vida E & Arthur L. Goldstein Lunder Building
55 Fruit Street
Lunder Building LL3
Boston, MA 02114
Proton Therapy Center
30 Fruit Street
Boston, MA 02114
Phone: 617-726-0923 (Proton Inquiry Line: 617-724-1680)
Explore the Gynecologic Program
The Gynecologic Radiation Oncology Service is nationally recognized in the field of radiation oncology for providing comprehensive clinical care for women with primary cancers of the uterus, cervix, vulva, vagina, ovaries, and fallopian tubes. Centered on reproductive-tract tissues, gynecologic radiation therapy requires exceptional precision to minimize the impact of treatment on sexual, hormonal, and reproductive functions. Our radiation oncologists' extensive knowledge of reproductive anatomy and physiology, combined with their expertise in radiation therapy, make them exceptionally qualified to treat women with gynecologic cancers.
Clinical Services and Special Programs
- Brachytherapy: Our service has made significant clinical advancement with the treatment of medically inoperable uterine cancers with intra-cavity brachytherapy using CT compatible titanium applicators and CT-based Dosimetry
- Consolidative or whole abdomen radiation treatment: Following surgery and chemotherapy for patients with FIGO stage III and abdomen-confined stage IV cancers of the uterus, this treatment employs intensity modulated radiation therapy (IMRT)
- Sequential tri-modality therapy: Patients with FIGO stages IIC1 and IIIC2 uterine cancers with extra-uterine cancer limited to retroperitoneal nodes are treated with surgery, adjuvant systemic chemotherapy, and consolidative extended volume pelvic/ para-aortic node radiation
- Proton Therapy: As a pioneer of proton therapy, Mass General offers multi-modality treatment of cancer of the uterus with metastases to regional nodes
Areas of Excellence
Mass General offers multi-modality treatment of cancer of the uterus with metastases to regional nodes (stage IIIC), where Mass General clinical outcomes are currently among the best reported in the medical literature (in excess of 80% five-year relapse-free actuarial survival).
Massachusetts General Hospital invites patients and the community to participate in innovative clinical trials and research studies.
Meet the Team
This pdf describes what you can expect before and during your radiation treatments.
Browse our online guides to visualize steps throughout the radiation oncology process.
- Patient Story
- Feb | 23 | 2017
Iris Martinez has had a whirlwind year. She has endured two minor surgeries, two major (surgeries), four rounds of chemotherapy, and two stem-cell transplants, and has completed her treatment.